Biglycan Is a Positive Modulator of BMP-2 Induced Osteoblast Differentiation
- 1 January 2006
- book chapter
- Published by Springer Nature
- Vol. 585, 101-113
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Extracellular Matrix Proteoglycans Control the Fate of Bone Marrow Stromal CellsJournal of Biological Chemistry, 2005
- BMP receptor signaling: Transcriptional targets, regulation of signals, and signaling cross-talkCytokine & Growth Factor Reviews, 2005
- The small leucine‐rich proteoglycan biglycan modulates BMP‐4‐induced osteoblast differentiationThe FASEB Journal, 2004
- Control of osteoblast function and regulation of bone massNature, 2003
- Functional Heterogeneity of Bone Morphogenetic Protein Receptor-II Mutants Found in Patients with Primary Pulmonary HypertensionMolecular Biology of the Cell, 2002
- Chordin-like CR domains and the regulation of evolutionarily conserved extracellular signaling systemsGene, 2002
- The Mode of Bone Morphogenetic Protein (BMP) Receptor Oligomerization Determines Different BMP-2 Signaling PathwaysJournal of Biological Chemistry, 2002
- Age-Related Osteoporosis in Biglycan-Deficient Mice Is Related to Defects in Bone Marrow Stromal CellsJournal of Bone and Mineral Research, 2002
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Novel Regulators of Bone Formation: Molecular Clones and ActivitiesScience, 1988